DMC is a privately-held company, producing bio-based chemicals using fermentation. Many chemicals are too expensive today for broad market adoption, such as certain amino acids for animal feed or natural cleaning agents for personal care. These products can be made more affordably and reliably using our technology.
We believe in sustainability and economic viability. Our patented technology makes products with lower energy and resource use, with applications that can contribute to a more sustainable economy.
We believe in sustainability and economic viability. Our patented technology makes products with lower energy and resource use, with applications that can contribute to a more sustainable economy.
Location: United States, Colorado, Boulder
Employees: 11-50
Total raised: $46.05M
Founded date: 2014
Investors 5
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Cibus Fund | cibusfund.... |
| - | Breakthrou... | breakthrou... |
| - | Quest for ... | questforgr... |
| - | Capricorn ... | capricorn.... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 02.12.2021 | Series B | $34M | Quest for ... |
| 09.07.2019 | Series A | $10.3M | - |
| 09.01.2018 | - | $1.75M | Capricorn ... |
Mentions in press and media 14
| Date | Title | Description |
| 27.06.2024 | Why Danone Bet on Precision Fermentation & ‘White Biotech’ for the Future of Food | 5 Mins Read French dairy giant Danone is part of a consortium that aims to scale up precision fermentation via a new open platform – in an interview, the company explains its thinking behind the move. Danone aims to ramp up its innovation c... |
| 14.06.2024 | Danone to Open Precision Fermentation Center ‘Biotech Open Platform’ in France with Strategic Players | French dairy giant Danone, engineered materials group Michelin, the US startup DMC Biotechnologies, and Crédit Agricole Centre France have partnered to create the Biotech Open Platform. The new center will focus on precision fermentation, a... |
| 05.01.2022 | DMC Appoints Ashley Jenkins as CFO | Boulder CA, USA: 5 January 2022 – DMC Biotechnologies has appointed Ashley Jenkins as Chief Financial Officer (CFO). Ashley joins DMC from Felix Energy where she has worked since 2013. Ashley joins DMC’s Boulder, Colorado office. |
| 03.12.2021 | DMC Biotechnologies Closes $34M First Close of Series B Funding | DMC Biotechnologies, a Boulder, CO and Durham, NC-based biobased chemical company that makes products using microbial fermentation, completed the first close of its Series B fundraising, raising $34m (USD). Backers included Cibus Enterprise... |
| 02.12.2021 | Quest for Growth : invests 1.7 million USD in DMC | Press release Leuven / 2 December 2021 QUEST FOR GROWTH Privak/pricaf, public alternative investment fund (AIF) with fixed capital under Belgian law Quest for Growth invests 1.7 million USD in DMC Biotechnologies DMC Biotechnologies has clo... |
| 02.12.2021 | Capricorn Further Invests in DMC Series B | Leuven, Belgium: 2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy V... |
| 13.05.2021 | DMC’s Downstream Processing Proven At Scale | Boulder, CO, USA: 13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstrati... |
| 22.04.2021 | DMC and Conagen partner for commercial manufacturing of L-alanine | Boulder, CO, USA: 21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. |
| 24.03.2021 | DMC CTO & Co-Founder Mike Lynch publishes Technoeconomic Analysis (TEA) Calculator to take the guesswork out of bioprocess development | Boulder, CO, USA: 24 March 2021 – DMC CTO and Co-Founder Mike Lynch has launched a web-based calculator to assess the economic feasibility of products made from fermentation. The Bioprocess Technoeconomic Analysis (TEA) tool will help users... |
| 15.03.2021 | DMC demonstrates full commercial scale at record speed | Boulder, CO, USA: 15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. |
Show more